Gracecast Lung Cancer Audio
ASCO 2012 LC Highlights: Dr. Joel Neal on the MEK Inhibitor Selumetinib in KRAS Mutation-Positive NSCLC (audio)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:05:10
- More information
Informações:
Synopsis
Dr. Joel Neal reviews the favorable results with chemo combined with the novel targeted therapy selumetinib, a MEK inhibitor, in KRAS mutatino-positive patients with advanced non-small cell lung cancer (NSCLC).
